This test is most useful if any of these apply to you.
Most lab tests measure something your own cells make. This one is different. Tricarballylic acid in urine reflects what gut microbes are doing, specifically bacteria that act on aconitate and citrate-related compounds from food and leave this molecule behind as an end product. Its clinical utility in humans has not been validated by major medical societies, so it is best treated as a research-stage signal rather than a diagnostic test.
That makes it an exploratory window into gut microbial output, not a diagnostic test for any single disease. It is a bacterial metabolite, not a fungal one, even though some functional-medicine panels group it alongside markers that practitioners associate with yeast activity.
Tricarballylic acid (propane-1,2,3-tricarboxylate) is not a known product of human metabolism. The clearest mechanistic data come from rumen microbiology in cattle, where bacteria such as Selenomonas ruminantium reduce trans-aconitate to tricarballylate. Whether the same pathway operates in the human gut has not been directly demonstrated, though it has been classified in humans as a xeno-metabolite (a molecule not made by your own cells) of microbial or dietary origin.
Animal data also show that tricarballylate is absorbed through gut transporters shared with citrate. The transporter family involved is conserved in humans, but the absorption pathway has not been directly confirmed in human intestinal tissue. Because the molecule travels through the body without being processed by your own cells, it serves as a chemical signature of microbial activity. Whether more of it in urine is good or bad depends on what is happening in your gut, which is why this test is read alongside other gut-related markers rather than against a fixed cutoff.
The clearest human data come from a small pilot study of endurance athletes, where urinary tricarballylic acid tracked with one of the two largest bacterial groups in the gut. People with more Firmicutes bacteria in their stool tended to have more tricarballylic acid in their urine, a moderate-to-strong link (correlation around 0.66, where 1.0 would be a perfect match).
In the same study, urinary tricarballylic acid fell along with arabinose, 3-oxoglutaric acid, and tartaric acid after the athletes drank a fermented soymilk extract. The study authors associated those companion markers with yeast and fungal activity, but tricarballylic acid itself is produced by bacteria. The parallel movement is a co-occurrence in one small unblinded study, not evidence that tricarballylic acid is a fungal marker.
In obese, insulin-resistant women, a combined program of weight loss and exercise was followed by higher plasma tricarballylic acid after a glucose drink. The study's main point was that gut-derived xeno-metabolites contribute to the metabolic signatures researchers see in the blood, rather than that tricarballylic acid itself tracks improvement in any clinically meaningful way. This evidence is from blood rather than urine, so it points to a biological connection rather than direct proof about the urinary measurement.
Being clear about what tricarballylic acid is not matters. Studies looking at urinary markers of kidney disease progression in type 2 diabetes have measured other compounds in the same general family, such as citrate, fumarate, and malate, and found them useful for predicting which patients move toward end-stage kidney disease. Those findings do not transfer to tricarballylic acid, which was not measured in those studies.
In Behcet's disease, an autoimmune condition, blood (not urine) levels of tricarballylic acid were lower than in healthy controls and correlated with specific gut bacterial families. That is interesting context for the gut-microbe story, but it is a serum finding in a small study, not a urinary diagnostic for autoimmune disease.
Urinary tricarballylic acid is a research-stage marker without standardized clinical cutoffs, and its level reflects a moving target: what you have been eating, which microbes have grown, and how those microbes have been working over recent days. A single reading is a snapshot of a system that changes constantly.
Treat the first result as a baseline. If you are running an intervention aimed at gut balance, retesting after a few months can show whether your number is moving along with how you feel and along with other gut markers. Because no clinical guidelines define an interval, any retesting schedule should be a personal decision made with a clinician, not a recommendation backed by outcome data. The trajectory across several samples carries more meaning than any single value.
A single urinary reading can be thrown off by several factors that do not reflect any real shift in your gut microbes.
Because tricarballylic acid is exploratory and has no clinical guideline behind it, a single high or low value is not a reason to act in isolation. Some functional medicine practitioners interpret it alongside arabinose, tartaric acid, and other markers they associate with yeast activity, though this interpretation is not supported by mainstream clinical evidence.
If your tricarballylic acid is unusual alongside several other organic acid markers, that pattern is worth a conversation with a clinician who works with gut health, such as a gastroenterologist, registered dietitian, or functional medicine physician familiar with organic acid testing. If it is high in isolation while the rest of your panel looks ordinary, the more useful next step is to repeat the test after a few months of consistent diet and any planned changes, then look at the trend rather than reacting to one number.
Evidence-backed interventions that affect your Tricarballylic Acid level
Tricarballylic Acid is best interpreted alongside these tests.
Tricarballylic Acid is included in these pre-built panels.